518 related articles for article (PubMed ID: 27633463)
21. HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.
Prévost J; Medjahed H; Vézina D; Chen HC; Hahn BH; Smith AB; Finzi A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835042
[TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants.
Naiman NE; Slyker J; Richardson BA; John-Stewart G; Nduati R; Overbaugh JM
EBioMedicine; 2019 Sep; 47():257-268. PubMed ID: 31501077
[TBL] [Abstract][Full Text] [Related]
23. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
Heredia JD; Park J; Choi H; Gill KS; Procko E
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
[TBL] [Abstract][Full Text] [Related]
24. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.
Ferrari G; Pollara J; Kozink D; Harms T; Drinker M; Freel S; Moody MA; Alam SM; Tomaras GD; Ochsenbauer C; Kappes JC; Shaw GM; Hoxie JA; Robinson JE; Haynes BF
J Virol; 2011 Jul; 85(14):7029-36. PubMed ID: 21543485
[TBL] [Abstract][Full Text] [Related]
25. Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.
Veillette M; Richard J; Pazgier M; Lewis GK; Parsons MS; Finzi A
Curr HIV Res; 2016; 14(1):9-23. PubMed ID: 26310828
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.
Li Y; O'Dell S; Wilson R; Wu X; Schmidt SD; Hogerkorp CM; Louder MK; Longo NS; Poulsen C; Guenaga J; Chakrabarti BK; Doria-Rose N; Roederer M; Connors M; Mascola JR; Wyatt RT
J Virol; 2012 Oct; 86(20):11231-41. PubMed ID: 22875963
[TBL] [Abstract][Full Text] [Related]
27. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
28. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
Dennison SM; Anasti KM; Jaeger FH; Stewart SM; Pollara J; Liu P; Kunz EL; Zhang R; Vandergrift N; Permar S; Ferrari G; Tomaras GD; Bonsignori M; Michael NL; Kim JH; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Liao HX; Haynes BF; Alam SM
J Virol; 2014 Aug; 88(16):9406-17. PubMed ID: 24920809
[TBL] [Abstract][Full Text] [Related]
29. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
J Virol; 2019 May; 93(10):. PubMed ID: 30842324
[TBL] [Abstract][Full Text] [Related]
30. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region.
Tolbert WD; Gohain N; Alsahafi N; Van V; Orlandi C; Ding S; Martin L; Finzi A; Lewis GK; Ray K; Pazgier M
Structure; 2017 Nov; 25(11):1719-1731.e4. PubMed ID: 29056481
[TBL] [Abstract][Full Text] [Related]
32. Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.
Richard J; Prévost J; Baxter AE; von Bredow B; Ding S; Medjahed H; Delgado GG; Brassard N; Stürzel CM; Kirchhoff F; Hahn BH; Parsons MS; Kaufmann DE; Evans DT; Finzi A
mBio; 2018 Mar; 9(2):. PubMed ID: 29559570
[TBL] [Abstract][Full Text] [Related]
33. CD4 mimetics sensitize HIV-1-infected cells to ADCC.
Richard J; Veillette M; Brassard N; Iyer SS; Roger M; Martin L; Pazgier M; Schön A; Freire E; Routy JP; Smith AB; Park J; Jones DM; Courter JR; Melillo BN; Kaufmann DE; Hahn BH; Permar SR; Haynes BF; Madani N; Sodroski JG; Finzi A
Proc Natl Acad Sci U S A; 2015 May; 112(20):E2687-94. PubMed ID: 25941367
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
[TBL] [Abstract][Full Text] [Related]
35. Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir.
Rajashekar JK; Richard J; Beloor J; Prévost J; Anand SP; Beaudoin-Bussières G; Shan L; Herndler-Brandstetter D; Gendron-Lepage G; Medjahed H; Bourassa C; Gaudette F; Ullah I; Symmes K; Peric A; Lindemuth E; Bibollet-Ruche F; Park J; Chen HC; Kaufmann DE; Hahn BH; Sodroski J; Pazgier M; Flavell RA; Smith AB; Finzi A; Kumar P
Cell Host Microbe; 2021 Jun; 29(6):904-916.e6. PubMed ID: 34019804
[TBL] [Abstract][Full Text] [Related]
36. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
Crooks ET; Tong T; Chakrabarti B; Narayan K; Georgiev IS; Menis S; Huang X; Kulp D; Osawa K; Muranaka J; Stewart-Jones G; Destefano J; O'Dell S; LaBranche C; Robinson JE; Montefiori DC; McKee K; Du SX; Doria-Rose N; Kwong PD; Mascola JR; Zhu P; Schief WR; Wyatt RT; Whalen RG; Binley JM
PLoS Pathog; 2015 May; 11(5):e1004932. PubMed ID: 26023780
[TBL] [Abstract][Full Text] [Related]
37. Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial.
Tolbert WD; Van V; Sherburn R; Tuyishime M; Yan F; Nguyen DN; Stanfield-Oakley S; Easterhoff D; Bonsignori M; Haynes BF; Moody MA; Ray K; Ferrari G; Lewis GK; Pazgier M
mBio; 2020 Jun; 11(3):. PubMed ID: 32605979
[TBL] [Abstract][Full Text] [Related]
38. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
Prévost J; Richard J; Ding S; Pacheco B; Charlebois R; Hahn BH; Kaufmann DE; Finzi A
Virology; 2018 Feb; 515():38-45. PubMed ID: 29248757
[TBL] [Abstract][Full Text] [Related]
39. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
40. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Zhou T; Xu L; Dey B; Hessell AJ; Van Ryk D; Xiang SH; Yang X; Zhang MY; Zwick MB; Arthos J; Burton DR; Dimitrov DS; Sodroski J; Wyatt R; Nabel GJ; Kwong PD
Nature; 2007 Feb; 445(7129):732-7. PubMed ID: 17301785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
